The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials

OBJECTIVE: Daptomycin, a cyclic lipopeptide that exhibits rapid, concentration-dependent bactericidal activity in vitro against a broad spectrum of Gram-positive pathogens, has now, since 2003, been approved in more than 70 countries and regions to treat skin and soft-tissue infections (SSTIs). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shou Zhen, Hu, Jun Tao, Zhang, Chi, Zhou, Wei, Chen, Xian Feng, Jiang, Liang Yan, Tang, Zhan Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078778/
https://www.ncbi.nlm.nih.gov/pubmed/24961714
http://dx.doi.org/10.1136/bmjopen-2013-004744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078778/
https://www.ncbi.nlm.nih.gov/pubmed/24961714
http://dx.doi.org/10.1136/bmjopen-2013-004744

Ejemplares similares